Cellular Logistics

Cellular Logistics

Biotechnology, 504 S Rosa Rd Ste 200, Madison, Wisconsin, 53719, United States, 1-10 Employees

cellogistics.com

  • facebook
  • LinkedIn

Who is CELLULAR LOGISTICS

Cellular Logistics, Inc. (CL) is a U.S. life sciences company that is dedicated to improving the lives of individuals who suffer from heart failure. CL was founded in 2016 by a multi-disc...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2836

checked-icon Does something look wrong? Fix it. | View contact records from CELLULAR LOGISTICS

Cellular Logistics Org Chart and Mapping

Alex Vodenlich

Chief Executive Officer

Employees

Amish Raval

Board Chairman and Founder

Similar Companies to Cellular Logistics

BellBrook Labs

  • 11-50 11-50
  • 10 Million to 25 Million $ 10 Million to 25 Million

Intuitive Biosciences

  • 11-50 11-50
  • 5 Million to 10 Million $ 5 Million to 10 Million

JangoBio

  • 1-10 1-10
  • 1 Million to 5 Million $ 1 Million to 5 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Cellular Logistics

Answer: Cellular Logistics's headquarters are located at 504 S Rosa Rd Ste 200, Madison, Wisconsin, 53719, United States

Answer: Cellular Logistics's official website is https://cellogistics.com

Answer: Cellular Logistics's revenue is Under $1 Million

Answer: Cellular Logistics's SIC: 2836

Answer: Cellular Logistics has 1-10 employees

Answer: Cellular Logistics is in Biotechnology

Answer: Cellular Logistics top competitors include: BellBrook Labs , Intuitive Biosciences , JangoBio

Answer: Cellular Logistics contact info: Phone number: Website: https://cellogistics.com

Answer: Cellular Logistics, Inc. (CL) is a U.S. life sciences company that is dedicated to improving the lives of individuals who suffer from heart failure. CL was founded in 2016 by a multi-disciplinary team of physicians, scientists and business entrepreneurs at the University of Wisconsin-Madison. Our vision is to advance myocardial reparative and regenerative therapies that are poised to treat patients with heart failure. Our product promises to revitalize damaged heart tissue and improve outcomes for the estimated 30 million patients worldwide projected to suffer from heart failure by 2030.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access